Web Results

en.wikipedia.org/wiki/Wyeth_v._Levine

Wyeth v. Levine, 555 U.S. 555 (2009), is a United States Supreme Court case holding that Federal regulatory clearance of a medication does not shield the manufacturer from liability under state law. Contents. [hide]. 1 Facts. 1.1 Vermont jury trial; 1.2 Phenergan's regulatory background; 1.3 Wyeth's motion for judgment as a ...

www.supremecourt.gov/opinions/10pdf/09-152.pdf

Feb 22, 2011 ... BRUESEWITZ v. WYETH LLC. Syllabus provides that “[n]o vaccine manufacturer shall be liable in a civil ac- tion for damages arising from a vaccine-related injury ..... 1982); Stone v. Smith, Kline & French Labs., 447 So. 2d 1301, 1303–. 1304 ( Ala. 1984); Lindsay v. Ortho Pharm. Corp., 637 F. 2d 87, 90–91.

www.ca6.uscourts.gov/opinions.pdf/11a0271p-06.pdf

Sep 22, 2011 ... Smith, et al. v. Wyeth, Inc., et al. Page 3. 1. Although Smith and Wilson claim to have consumed only generic metoclopramide, plaintiff. Morris does assert that he consumed some Reglan manufactured by Wyeth (but not Schwarz), a fact that. Wyeth did not contest before the district court. Morris, however, has ...

caselaw.findlaw.com/nj-superior-court/1305890.html

Sep 23, 2003 ... Case opinion for NJ Superior Court SMITH v. AMERICAN HOME PRODUCTS CORP WYETH AYERST PHARMACEUTICAL. Read the Court's full decision on FindLaw.

respectfulinsolence.com/2011/02/23/the-supreme-court-rules-on-bruesewitz-v

Feb 23, 2011 ... Then, in March 2010, SCOTUS agreed to hear Bruesewitz v. Wyeth. The case involves Hannah Bruesewitz, who was born in 1991. Hannah received the first three shots of DPT, and after the third injection developed seizures. The parents presented a claim in Vaccine Court, but lost. As a consequence, they ...

www.mondaq.com/unitedstates/x/290294/food+drugs+law/Lance+v+Wyeth+A+New+Cause+Of+Action+In+Pennsylvania

Feb 3, 2014 ... Issuing an opinion over two years after oral argument, the Pennsylvania Supreme Court ruled last week in Lance v. Wyeth that pharmaceutical companies can be held liable for negligence in the design and marketing of drugs. United States Food, Drugs, Healthcare, Life Sciences Morrison & Foerster LLP 3 ...

www.scotusblog.com/case-files/cases/bruesewitz-v-wyeth

Holding: The National Childhood Vaccine Injury Act, which created a no-fault program to provide compensation for vaccine-related injuries, preempts all design-defect claims against vaccine manufacturers by individuals seeking compensation for injury or death. (Kagan, J., recused.) Plain English Holding: The National ...

law.justia.com/cases/federal/district-courts/FSupp/666/1483/2150760

745 (thoroughly discusses the *1494 NCVIA and finds it evidences congressional intent not to preempt); Smith v. Wyeth Laboratories, No. 84-2002 (S.D.W.Va. Aug. 21, 1986); Jeski v. Connaught Laboratories, No. A-84-CA-395, (W.D.Tex. Dec. 18 , 1986); Milam v. American Cyanamid, No. 4-85-92-K (N.D.Tex. Oct. 15, 1986).

www.courtswv.gov/supreme-court/docs/fall2010/35296.htm

Pt. 1, Gallapoo v. Wal-Mart Stores, Inc., 197 W.Va. 172, 475 S.E.2d 172 (1996). 2. “In ascertaining legislative intent, effect must be given to each part of the statute and to the statute as a whole so as to accomplish the general purpose of the legislation.” Syl. Pt. 2, Smith v. State Workmen's Compensation Commissioner, 159 ...